Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study.

Bidulka, Patrick; Iwagami, Masao; Mansfield, Kathryn E; Kalogirou, Fotini; Wong, Angel YS; Douglas, Ian J; Smeeth, Liam; Summers, Charlotte; Tomlinson, Laurie A; (2020) Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study. Wellcome Open Research, 5. 77-. DOI: https://doi.org/10.12688/wellcomeopenres.15873.1

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.12688/wellcomeopenres.15873.1

Abstract

Share

Download

Filename: comparisons_publishedversion_pdf.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar